Managing Tardive Dyskinesia in Clinical Practice: How Far Have We Come?

Managing Tardive Dyskinesia in Clinical Practice: How Far Have We Come? is organized by Postgraduate Institute for Medicine (PIM)

Release Date: Sep 20, 2019
Valid for credit through Sep 20, 2020.

Accreditation:
•  The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. 
• The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hour. Designated for 0.2 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.
• Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education.
• This program offers 1.0 continuing education credits for psychologists

Learning Objectives:
After completing this activity, the participant should be better able to:
• Discuss the prevalence and diagnostic criteria for TD in psychiatric patients
• Identify TD using the AIMS examination
• Formulate evidence-based treatments for TD, considering both efficacy and tolerability

Additional details will be posted as soon as information is available.